These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3105104)

  • 41. CGS 15435A, a thromboxane synthetase inhibitor with an extended duration of action: a comparison with dazoxiben.
    Olson RW; Cohen DS; Ku EC; Kimble EF; Renfroe HB; Smith EF
    Eur J Pharmacol; 1987 Jan; 133(3):265-73. PubMed ID: 3104066
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biochemical selectivity of oral versus intravenous aspirin in rats. Inhibition by oral aspirin of cyclooxygenase activity in platelets and presystemic but not systemic vessels.
    Cerletti C; Gambino MC; Garattini S; de Gaetano G
    J Clin Invest; 1986 Jul; 78(1):323-6. PubMed ID: 3088044
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo effects of defibrotide on platelet c-AMP and blood prostanoid levels.
    Cizmeci G
    Haemostasis; 1986; 16 Suppl 1():31-5. PubMed ID: 3011617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma thromboxane B2 levels and thromboxane B2 production by platelets are increased in patients during spinal and epidural anesthesia.
    Kaukinen S; Ojanen R; Kaukinen L; Seppälä E; Vapaatalo H
    Prostaglandins Leukot Essent Fatty Acids; 1989 Aug; 37(2):83-8. PubMed ID: 2780766
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute arterial thrombosis in rabbits: reduced platelet accumulation after treatment with dazoxiben hydrochloride (UK 37,248-01).
    Randall MJ; Wilding RI
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):49S-55S. PubMed ID: 6687429
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of imidazo[1,5-a]pyridine-5-hexanoic acid (CGS 13080) as a selective thromboxane synthetase inhibitor using in vitro and in vivo biochemical models.
    Ku EC; McPherson SE; Signor C; Chertock H; Cash WD
    Biochem Biophys Res Commun; 1983 May; 112(3):899-906. PubMed ID: 6687803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute arterial thrombosis in rabbits: reduced platelet accumulation after treatment with thromboxane synthetase inhibitor dazoxiben hydrochloride, (UK-37, 248-01).
    Randall MJ; Wilding RI
    Thromb Res; 1982 Dec; 28(5):607-16. PubMed ID: 6897751
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of exercise and ticlopidine on platelet function and prostanoids in patients with old myocardial infarction.
    Ding YA; Lee KW; Liang YB; Chang HC; Lin KC
    Taiwan Yi Xue Hui Za Zhi; 1989 Aug; 88(8):765-71. PubMed ID: 2592938
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the effects of oral and intravenous aspirin administration on platelet and peripheral vascular cyclo-oxygenase activity: studies in rats and in man.
    Cerletti C; Gambino MC; Bucchi F; Rajtar G; Riva E; de Goetano G
    Agents Actions Suppl; 1986; 20():239-48. PubMed ID: 3101444
    [No Abstract]   [Full Text] [Related]  

  • 50. Platelet aggregation and evaluation of the ratio thromboxane B2/6-keto-prostaglandin F1 alpha in the plasma of patients on long term cimetidine treatment.
    Zavagli G; Taddeo U; Bolelli G; Orlandi M; Bartolini G; Tomasi V
    Prostaglandins Leukot Med; 1985 Sep; 19(3):241-50. PubMed ID: 2997804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of platelet aggregation by prostacyclin is attenuated after exercise in patients with angina pectoris.
    Kishi Y; Ashikaga T; Numano F
    Am Heart J; 1992 Feb; 123(2):291-7. PubMed ID: 1736562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of 1 gram oral or intravenous aspirin on urinary excretion of thromboxane B2 and 6-keto-PGF1 alpha in healthy subjects.
    Bucchi F; Bodzenta A; de Gaetano G; Cerletti C
    Prostaglandins; 1986 Nov; 32(5):691-701. PubMed ID: 3103169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular and pulmonary effects of thromboxane B2 in the dog.
    Friedman LS; Fitzpatrick TM; Bloom MF; Ramwell PW; Rose JC; Kot PA
    Circ Res; 1979 Jun; 44(6):748-51. PubMed ID: 428069
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modification of prostaglandin synthesis in washed human platelets and cultured bovine aortic endothelial cells by glycosylated low density lipoprotein.
    Ishii H; Umeda F; Kunisaki M; Yamauchi T; Nawata H
    Diabetes Res; 1989 Dec; 12(4):177-82. PubMed ID: 2637093
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of CV-4151, a selective inhibitor of thromboxane synthetase, on prostanoid formation and platelet aggregation in humans.
    Kuzuya T; Kimura Y; Hoshida S; Kodama K; Nakamura N; Hamanaka Y; Kitabatake A; Kamada T; Tada M
    Cardiovasc Drugs Ther; 1988 Dec; 2(5):693-700. PubMed ID: 3154645
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Platelets from aged rats aggregate more, but are more sensitive to prostacyclin.
    Giani E; Masi I; Galli C
    Prostaglandins Leukot Med; 1985 Dec; 20(3):237-46. PubMed ID: 3003760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prolongation of rat tail bleeding time caused by oral doses of a thromboxane synthetase inhibitor which have little effect on platelet aggregation.
    Butler KD; Maguire ED; Smith JR; Turnbull AA; Wallis RB; White AM
    Thromb Haemost; 1982 Feb; 47(1):46-9. PubMed ID: 6461944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological, hematological, and physiological effects of a new thromboxane synthetase inhibitor (CGS-13080) during cardiopulmonary bypass in dogs.
    DeCampli WM; Goodwin D; Kosek JC; Handen CE; Mitchell RS; Miller DC
    Ann Thorac Surg; 1986 Dec; 42(6):690-6. PubMed ID: 3789860
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of single oral doses of lysine clonixinate and acetylsalicylic acid on platelet functions in man.
    Pallapies D; Muhs A; Bertram L; Rohleder G; Nagyiványi P; Peskar BA
    Eur J Clin Pharmacol; 1996; 49(5):351-4. PubMed ID: 8866627
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of thromboxane biosynthesis in serum: limitations of the measurement of immunoreactive 6-keto-PGF1 alpha.
    Pedersen AK; Watson ML; FitzGerald GA
    Thromb Res; 1984 Jan; 33(1):99-103. PubMed ID: 6546456
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.